chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever/slight fever; painful rash around shot; red and puffy face; red and puffy face; Chills; headache; This is a spontaneous report from a contactable consumer(patient).   A 42-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8731) via an unspecified route of administration, administered in left arm on 20Apr2021 10:00 (at the age of 42-year-old) as dose 2, single for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included fibroids, pre-diabetes, asthma from an unknown date and unknown if ongoing and known unspecified allergies to Penicillin from an unknown date and unknown if ongoing. Concomitant medications included metformin, tri-lo sprintec, spirolatcone, zyrtec/allertec, Montelukast and melatonin taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6205) administered in left arm on 23Mar2021 12:00 PM for COVID-19 immunisation. On 20Apr202110:00, the patient experienced red and puffy face, at night she had chills and headache. On second day (21Apr2021) patient had chills, headache, fever and painful rash around shot. On third day (22Apr2021), patient experienced headache, slight fever in the morning, gone by afternoon and painful rash slowly going away on next day. No treatment was taken for adverse events. No Covid prior vaccination. Since the vaccination, the patient had been tested with SDTL SARS-CoV-2 Viral Nucleic Acid Viral Test for COVID-19 of which results are pending at the time of reporting. The patient did not receive any other vaccines within four weeks prior to the vaccination. Outcome of the events headache and slight fever recovered on unspecified date and rest events were recovered on unspecified date.  No follow-up attempts are needed. No further information is expected.
I received a Flu shot and during the day my arm hurt a lot. The next day my arm still hurt and I noticed a big bruise on my arm. I still have the bruise and my arm still hurt.
Flu symptoms, severe headache, upset stomach and nausea, loose stool, bone and joint pain.
Patient had bruising at the site of injection and while it has mostly resolved there, the bruising has traveled to the inside of her arm where it is a darker purple today (6/18/21). She says she is quite sore and has had difficulty moving her arm. She says she noticed the bruising on 6/16/21 and thought to come talk to us about it at that time.
Patient reports tightness in neck, hard time breathing, excessive sweating, fever, and heart flutter presenting at night as well as local swelling. Symptoms were better during the day, some symptoms worsen again while relaxing 8/4.
Missed the second dose because of surgery; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed the second dose because of surgery) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 2033B21A and 044A01) for COVID-19 vaccination.     The patient's past medical history included Surgery (2nd Dose Delayed due to Surgery).   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the second dose because of surgery). On 28-May-2021, PRODUCT DOSE OMISSION ISSUE (Missed the second dose because of surgery) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment was reported.
label she noticed it said 0.5 or 0.25 mL based on age and it was confusing for her; Circumstance or information capable of leading to medication error; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT LABEL CONFUSION (label she noticed it said 0.5 or 0.25 mL based on age and it was confusing for her), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT LABEL CONFUSION (label she noticed it said 0.5 or 0.25 mL based on age and it was confusing for her), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT LABEL CONFUSION (label she noticed it said 0.5 or 0.25 mL based on age and it was confusing for her), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT LABEL CONFUSION (label she noticed it said 0.5 or 0.25 mL based on age and it was confusing for her) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error).    No concomitant medication was reported.  Reporter stated that the dosage of Moderna COVID-19 Vaccine, Bivalent was 0.5 mL, but in the label they noticed it said 0.5 or 0.25 mL based on age and it was confusing.  No treatment information was provided.   Reporter did not allow further contact
NUMBNESS/TINGLING TO TONGUE AND LIPS THAT PROGRESSED TO BURNING SENSATIONS TO RIGHT SIDE OF BODY LEAVING ME WITH PAIN IN RIGHT FLANK, LEG, R TORSO, R FOREARM AND RIGHT MEDIAL ELBOW AND RIGHT MEDIAL ARM. SEVERE BURNING PAIN TO ELBOW UP ARM ON RIGHT.
It was reported that an 8 month old patient who received 3 doses of ActHIB developed meningitis (possibly H Influenza type B). Final Lab report confirmed H Influenza type B. Further information is requested. From mailed follow-up contact on 06/06/2001, it was stated the female pt received an ActHIB vaccination on 10/04/2000 dose 1, 11/30/2000 dose 2, and on 02/08/2001 dose 3. After dose three, in May 2001, the pt developed Haemophilus influenzae type e. The pt was hospitalized. The pt reportedly recovered from this experience. From mailed correspondence received on 10/29/2001 it was reported: "Reviewed, no additional information at this time." No further info is anticipated for this report, this case is closed.
Received second vaccine dose. Lay on cot and began to have a seizure. Vitals obtained and rolled on side. EMS called   Complained of headache dizziness fatigue after woke from first seizure.  Then had another seizure.
soreness of the arm after the vaccine; numbness on two fingers/numb on the arm; Different reactions; Get totally numb on the arm; Radiating tingling sensation going up their arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness of the arm after the vaccine), HYPOAESTHESIA (numbness on two fingers/numb on the arm), VACCINATION SITE REACTION (Different reactions), HYPOAESTHESIA (Get totally numb on the arm) and PARAESTHESIA (Radiating tingling sensation going up their arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness of the arm after the vaccine), HYPOAESTHESIA (numbness on two fingers/numb on the arm), VACCINATION SITE REACTION (Different reactions), HYPOAESTHESIA (Get totally numb on the arm) and PARAESTHESIA (Radiating tingling sensation going up their arm). The patient was treated with VITAMIN B12 NOS for Adverse event, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PAIN (soreness of the arm after the vaccine), HYPOAESTHESIA (numbness on two fingers/numb on the arm), VACCINATION SITE REACTION (Different reactions) and PARAESTHESIA (Radiating tingling sensation going up their arm) outcome was unknown and HYPOAESTHESIA (Get totally numb on the arm) had resolved.            No concomitant medications were provided by the reporter. No treatment details were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow-Up information received on 28-JUN-2021 doesn't contain any significant information. On 28-Jun-2021: Follow-Up information received on 28-JUN-2021 doesn't contain any significant information.
Red rash at injection site; Red rash at injection site; This is a spontaneous report received from contactable reporter(s) (Pharmacist) from a sales representative.  A patient (no qualifiers provided) received pneumococcal 13-val conj vac (dipht CRM197 protein) (PNEUMOCOCCAL 13-VAL CONJ VAC (DIPHT CRM197 PROTEIN)), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE RASH (non-serious), VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown" and all described as "Red rash at injection site". Additional information: Red rash at injection site similar to that caused by the pneumonia vaccination. Event took place after use of product.  The information on the batch/lot number for pneumococcal 13-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
Pt developed initial induration at site of DTAP and polio vax which measured about 4 cm when seen at 24 hrs. Pt was treated symptomatically. She developed vesicles with crusts which resolved. 5 days post vax pt has since developed a similar area of induration on calf with denuded 1 cm ulcerative base of vesicle. Pt also has another smaller papule with about 1 cm of induration on right forearm.
headache; She felt like she was hit by a truck; her arm was sore for 3 days; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NVSC2021US190951.  A 49 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 49 years as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization; Bnt162b2 (Dose: 2), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache"; PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "her arm was sore for 3 days"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "She felt like she was hit by a truck".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
10/27/09 within 5 minutes of receiving H1N1 inactivated 2009 injection, c/o tingling from feet to head, c/o feeling strange, BP increased, c/o cold feeling running up back of bil. arms, fingers both hands turned white, c/o nausea approx. 30 min after injection given. Sent to ED for evaluation and treatment.  11/06/09 Mediocal records received for DOS 10/27/09. Final DX: Possible reaction. Patient felt strange s/p vaccine. Tingling , SOB, PE WNL. Self resolved. D/C to home.
On 4/10/2021, sore arm, chills, throbbing headache, fever between 100.4 and 102.3, shortness of breath
Pt recvd pneumococcal vax on 30NOV91 & exp a reaction but the MD was not specific about any signs or sx associated w/the reaction; No further details were provided;
Information has been received on 14-MAY-2018 regarding a case in litigation from a lawyer and a male consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 08-MAY-2014, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 26-MAY-2016, the patient was treated at a family medicine for the onset of a vesicular rash which was diagnosed as herpes zoster, or shingles. The patient has been prescribed valacyclovir hydrochloride (VALTREX) for management of his painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
pt recv vax 21MAY96 & 24MAY96 pt devel chickenpox which started w/a low grade fever progressing to lesions on 26MAY96;29MAY96 pt had over 200 lesions;
After taking the 3rd dose, I felt hung over. I had a headache and was tired. Also, my Brachial Plexus worsened. My fingers would bend in different directions and caused my shoulder & fingers to cramp. I also later contracted COVID-19. I was quite surprised when I received the result. I didn't have symptoms because I was testing regularly previously because I would visit my mother frequently. I was prescribed a five day course of PAXLOVID. I believe the medication I took made me fatigued for a couple of weeks and everything tasted like burning metal. But I'm not exactly sure if the medication or the COVID-19 diagnosis caused those issues.
COVID vaccine, Pfizer #1 given on 12/30/2021, lot # EL3246; COVID vaccine, Pfizer #2 given on 01/20/2021, lot # EL3302; 02/05/2022 pt presented to ED via EMS to be treated for COVID Pneumonia; had a positive test on 02/01/2022; pt continued to decline; was given remdesivir, zithromax, baricitinib, O2 supplementation; continued to worsen; DNR; had an episode of SVT, responded to metoprolol but was not able to maintain O2 sats above 80%; reverted back to SVT; went into respiratory arrest and asystole; he never recovered; death certificate and med records sent to VAERS website per VAERS request
Patient went in to Pharmacy for a FLU shot. She confirmed she was indeed only receiving the FLU shot, as she had decided she was done with the Covid Boosters upon realizing their atrocious safety profile and  nonexistent effectiveness  (or even NEGATIVE effectiveness). The "Pharmacist" who was contracted in from pharmacy, did not even work there, went ahead and gave her the Pfizer Bivlent booster "by accident", to which the patient first thought he was joking, but later realized he was dead serious. Patient was rightfully angry at the Massive Mistake this guy made and he then had the audacity to write it all off by saying "Hey at least youre not an anti-vaxxer". HORRIBLE EXPERIENCE! SMUG Arrogant injector is a stark reminder at how far gone our allopathic medical system truly is. Their arrogance, empty hubris, and carelessness with injection an unapproved, experimental gene therapy is adtonishing. Luckily the patient feels fine so far, but we have no idea of the longterm impact of these experimental therapies, and once it's injected, you're stuck with it, and she didn't even want the jab. A horrendous experience and a reminder for all to TRIPLE check the injector knows what they are doing  before you let them near you or your kids or loved ones. Stay safe out there!
Fever; This case was reported by a other health professional via call center representative and described the occurrence of fever in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE POLYSACCHARIDE 23 VALENT (PPSV23 (PNEUMOCOCCAL POLYSACCHARIDE VACCINE 23-VALENT)) for prophylaxis.   On 23rd June 2020, the patient received the 2nd dose of Shingrix and PPSV23 (PNEUMOCOCCAL POLYSACCHARIDE VACCINE 23-VALENT). In June 2020, 24 hrs after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was not recovered/not resolved.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and it was administered on the same day and on same arm where the patient received a PPSV23 vaccine and after 24 hours presented fever (101.5F) The reporter consented to follow up.  No patient DOB and no vaccines data was available.
Initial unsolicited report received from a physician on 13-May-2016. This case involves a 23-year-old male patients who was vaccinated with a first dose of YF-VAX (batch number UI268AA, expiry date: 08-Sep-2017) by subcutaneous route in the left arm on 03-May-2016. Patient's illness at time of vaccination was reported as none. Pre-existing physician diagnosed allergies, birth defects, medical conditions included: no known allergies. Concomitant medications were not reported. On 07-May-2016, four days following the vaccination, the patient experienced bilateral "hip discomfort" or joint pain. On 12-May-2016, nine days post vaccination, the patient developed a pink, papular rash over trunk and arms. Patient did not report any fever. Laboratory investigations and corrective treatment were not reported. The outcome of the events was reported as not recovered. It was reported that the patient's primary care physician had pronounced him "okay for now". List of documents held by sender: none.
Patient presented to clinic on 6/20/08 to show his right arm where he received his PNEUMOVAX injection (6/18/08). It was swollen and reddened and apparently tender. Patient states he has been taking TYLENOL and applying ice. Patient appeared eupneic and in no other distress. Nurse at clinic reported several (3 or 4) similar reactions to PNEUMOVAX of same lot. 3 remaining vials from same lot discarded and new lot ordered. Symptoms: 1. swollen, reddened arm (whole arm, not just injection site). Treatment Drugs Used: 1. Acetaminophen Dose: 325 Units: MG Free: QID Route: PO
I felt extreme chills at night, and could not sleep even with a ton of clothing and layers on, and even after taking sleep medication. Also, nausea, and fatigue (but I think fatigue is due to lack of sleep)
Moderna vax taken and started getting chest pains. Went to ER. Doc thought blood clots in the lungs. diagonostics revealed inflamation in the lungs
Initial information received on 27-Sep-2018 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2018SA272107 (Same reporter). This case involves a 74 years old female patient who experienced "very swollen arm", very red, it appeared a was boil coming from the side of swell and had been dizzy since the injection, while she received vaccine FLUZONE HIGH DOSE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included MECOBALAMIN (B12 RAPID SHOT) for Immunisation on an unknown date. On 25-Sep-2018, the patient received a 0.5 ml once dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot number: UJ023AA and expiry date: 25-Apr-2019) (dose in series and route of administration were not reported) in the left arm. On an unknown date, the patient developed a non-serious "very swollen arm" (peripheral swelling) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. On an unknown date, the patient developed a non-serious very red (erythema) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. On an unknown date, the patient developed a non-serious it appeared a was boil coming from the side of swell (furuncle) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. On an unknown date, the patient developed a non-serious had been dizzy since the injection (dizziness) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. It was reported that on 27-Sep-2018, patient was appointed to visit to the HCP. No Lab data was reported. Final diagnosis was had been dizzy since the injection, it appeared a was boil coming from the side of swell, very red and "very swollen arm". It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for very red, as Unknown for "very swollen arm", as Unknown for it appeared a was boil coming from the side of swell and as Unknown for had been dizzy since the injection.
Pain in arm, itching. Advised patient to place ice pack over area and take BENADRYL.
To the Er - C/O Severe pain (L) shoulder to (L) leg - including hip thigh, chest, & abdomen.
after shot I had arm pain 12/11 I woke up with chills. As the day progressed Both of my legs and arm started hurting and progressed. I called the pharmacist and they stated that they never heard of a reaction 5 days later. The next day the pain resolved in my leg and shoulders.
About 5 to 10 minutes after receiving the vaccination, the patient came back to the pharmacy. He had been walking around the store. He said he had visual disturbances combined with dizziness that resulted in him losing his balance and falling to the ground. We had him sit down in the pharmacy for 15 minutes to see if he had any other side effects. After 15 minutes, he said he was feeling much better. He said the dizziness had gone away and that he never had any issues with breathing or swelling. He left the pharmacy to go home.
Patient c/o heat beating fast. On initial   assessment she was noted to be tachycardia at 111. Benadryl was given. Pulse went down to 103- sent home. Advised to go to ER if she feels worse
This spontaneous report as received from a physician refers to a 12 year old patient of unknown gender. The patient's concurrent conditions, concomitant medications, pertinent medical history and drug reactions or allergies were not provided. On 06-SEP-2017, the patient was vaccinated with an improperly stored dose of GARDASIL 9, lot # M040412 with expiration date on 30-JUN-2019 (dose and route of administration were not reported). Since 19-MAY-2017, the administered dose of GARDASIL 9 underwent multiple temperature excursions between 33 degrees Fahrenheit and 50 degrees Fahrenheit, which lasted for 16, 40, 46 or 70 hours. A digital data logger was not involved in recording the excursion. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA012764.
Fever that rose throughout the day and into the night peaking at 102 degrees and resulting in violent chills and nausea, but no vomiting. Also experienced terrible muscle/joint soreness and weakness.